China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
13.25
-0.04 (-0.30%)
Nov 17, 2026, 3:04 PM CST

SHE:300294 Revenue

China Resources Boya Bio-pharmaceutical Group Co.,Ltd had revenue of 203.36M CNY in the quarter ending September 30, 2026, a decrease of -56.37%. This brings the company's total for the last twelve months to 1.43B, down -27.07% year-over-year. In the year 2025, China Resources Boya Bio-pharmaceutical Group Co.,Ltd had annual revenue of 2.06B with 18.69% growth. That makes China Resources Boya Bio-pharmaceutical Group Co.,Ltd the 17,013th largest company in the world by revenue and 3,092nd in China.

Revenue (ttm)
1.43B
Revenue Growth
-27.07%
P/S Ratio
4.69
Revenue / Employee
735.53K
Employees
1,947
Market Cap
6.68B

Revenue Chart

Revenue by Segment

  • Blood Products Business 1.67B 81.2%
  • Pharmaceutical Distribution Business 197.91M 9.6%
  • Biochemical Pharmaceutical Product 181.66M 8.8%
  • Other Business 8.49M 0.4%
Fiscal year ended Dec 31, 2025 See the full SHE:300294 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.06B324.18M18.69%
Dec 31, 20241.73B-917.08M-34.58%
Dec 31, 20232.65B-106.72M-3.87%
Dec 31, 20222.76B108.17M4.08%
Dec 31, 20212.65B137.49M5.47%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.